Literature DB >> 7526003

Correlation between serum prostate specific antigen levels and the volume of the individual glandular zones of the human prostate.

P G Hammerer1, J E McNeal, T A Stamey.   

Abstract

To analyze the correlation between serum prostate specific antigen (PSA) levels and the volume of the individual glandular zones of the human prostate, we examined 31 cystoprostatectomy specimens as well as 13 radical prostatectomy specimens with a prostate cancer volume of 0.3 cc or less, no bladder cancer infiltrating the prostate, no granulomas or severe inflammation, as well as no patient history of radiation, transurethral resection of the prostate or hormonal treatment. The volumes of the peripheral zone, transition zone and central zone were separately determined by outlining the zonal boundaries during microscopic examination of all slides at each level of section. PSA was measured by the Yang polyclonal assay. In the univariant regression analysis the correlation coefficients among serum PSA and transition zone, peripheral zone and central zone volumes were 0.934, 0.546 and 0.368, respectively, strongly suggesting that most PSA leakage from the prostate into the serum comes from the transition zone. The regression of serum PSA and transition zone volumes leads to a prediction of approximately 0.261 ng./ml. PSA per gm. benign prostatic hyperplasia (BPH) plus an intercept of 0.878, a number in keeping with our 1987 estimates of 0.3 ng./ml./gm. BPH. The volumes of the 3 zones appeared to be independent variables. Transition zone volume showed the greatest variation because of BPH. The mean average ratio of peripheral zone volume to central zone volume was nearly 3:1. These data strongly support the concept of age-adjusted PSA levels, since most of the increase in size of the prostate with increasing patient age comes from the transition zone from which BPH develops.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7526003     DOI: 10.1097/00005392-199501000-00038

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  12 in total

Review 1.  Prostate kallikrein markers in diagnosis, risk stratification and prognosis.

Authors:  David Ulmert; M Frank O'Brien; Anders S Bjartell; Hans Lilja
Journal:  Nat Rev Urol       Date:  2009-07       Impact factor: 14.432

2.  A new model consists of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of prostate cancer.

Authors:  Ding Xu; Yongjiang Yu; Yunkai Zhu; Tao Huang; Yaqing Chen; Jun Qi
Journal:  Pathol Oncol Res       Date:  2013-11-01       Impact factor: 3.201

Review 3.  Prostate cancer: 5. Diagnostic tools for early detection.

Authors:  P I Karakiewicz; A G Aprikian
Journal:  CMAJ       Date:  1998-11-03       Impact factor: 8.262

4.  Transition zone prostate specific antigen density improves prostate cancer detection in Iranian men.

Authors:  Mohammadreza Nowroozi; Mohsen Ayati; Hassan Jamshidian; Amir Arbab; Hamidreza Ghorbani; Erfan Amini; Hassan Hakima; Sohrab Salehi; Alireza Ghadian
Journal:  Nephrourol Mon       Date:  2015-03-20

5.  Advantages of replacing the total PSA assay with the assay for PSA-alpha 1-antichymotrypsin complex for the screening and management of prostate cancer.

Authors:  J T Wu; G H Liu
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

Review 6.  Tumour innervation and neurosignalling in prostate cancer.

Authors:  Brayden March; Sam Faulkner; Phillip Jobling; Allison Steigler; Alison Blatt; Jim Denham; Hubert Hondermarck
Journal:  Nat Rev Urol       Date:  2020-01-14       Impact factor: 14.432

7.  Prostate-specific antigen, prostate volume and transition zone volume in Japanese patients with histologically proven benign prostatic hyperplasia.

Authors:  Y Furuya; S Ohta; N Sato; T Kotake; M Masai
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

8.  Lack of correlation between prostate-specific antigen density and prostatic shrinkage in response to finasteride therapy.

Authors:  A Kirschenbaum; E Pacheco; B J Schuval; A C Levine
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

9.  Between-subject variations of transition zone epithelial volume and serum PSA levels in men with benign prostatic hyperplasia.

Authors:  Martella Oreste; Paradiso Galatioto Giuseppe; Pace Gianna; Angelucci Adriano; Necozione Stefano; Bologna Mauro; Vicentini Carlo
Journal:  World J Urol       Date:  2009-08-19       Impact factor: 4.226

Review 10.  Clinical Considerations for Intravesical Prostatic Protrusion in the Evaluation and Management of Bladder Outlet Obstruction Secondary to Benign Prostatic Hyperplasia.

Authors:  Jason Gandhi; Steven J Weissbart; Albert N Kim; Gunjan Joshi; Steven A Kaplan; Sardar Ali Khan
Journal:  Curr Urol       Date:  2018-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.